Dublin-based biopharmaceutical company Alkermes plc is making waves in the industry thanks to its groundbreaking pharmaceutical products catered towards unmet medical needs in various therapeutic areas. The company's marketed products include ARISTADA, a schizophrenia treatment, and VIVITROL, which helps prevent opioid and alcohol dependence. Its impressive repertoire also includes treatments geared towards bipolar disorder and multiple sclerosis. Alkermes is currently developing LYBALVI and nemvaleukin alfa, which have garnered significant attention in the medical community. The company has forged collaboration agreements with Janssen Pharmaceutica N.V., Janssen Pharmaceutica Inc, and Janssen Pharmaceutica International. Founded in 1987, Alkermes plc is a promising figure in the biopharmaceutical industry.
Alkermes's ticker is ALKS
The company's shares trade on the NASDAQ stock exchange
They are based in Dublin, Ireland
There are 1001-5000 employees working at Alkermes
It is alkermes.com
Alkermes is in the Healthcare sector
Alkermes is in the Biotechnology industry
The following five companies are Alkermes's industry peers: